{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T07:14:33Z","timestamp":1760426073059,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.schres.2022.02.035","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T17:47:33Z","timestamp":1646416053000},"page":"110-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Amitriptyline for clozapine-induced hypersalivation: A case series"],"prefix":"10.1016","volume":"243","author":[{"given":"Guido","family":"Cereda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Boscutti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Lazzaretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Enrico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Brambilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2022.02.035_bb0005","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1345\/aph.1P761","article-title":"Current treatment strategies for clozapine-induced sialorrhea","volume":"45","author":"Bird","year":"2011","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.schres.2022.02.035_bb0010","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0361-1124(79)80408-6","article-title":"Tricyclic antidepressant overdose","volume":"8","author":"Callaham","year":"1979","journal-title":"JACEP"},{"key":"10.1016\/j.schres.2022.02.035_bb0015","doi-asserted-by":"crossref","DOI":"10.1192\/bjp.159.1.166a","article-title":"Amitriptyline in clozapine-induced sialorrhoea","author":"Copp","year":"1991","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2022.02.035_bb0020","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.MY20096AH1C","article-title":"Treatment-resistant schizophrenia: definition, predictors, and therapy options","volume":"82","author":"Correll","year":"2021","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2022.02.035_bb0025","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1345\/aph.19259","article-title":"Clozapine-induced hypersalivation","volume":"34","author":"Davydov","year":"2000","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.schres.2022.02.035_bb0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/10401230309085668","article-title":"Clozapine: a clinical review of adverse effects and management","volume":"15","author":"Iqbal","year":"2003","journal-title":"Ann. Clin. Psychiatry offJ. Am. Acad. Clin. Psychiatr."},{"key":"10.1016\/j.schres.2022.02.035_bb0035","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/2045125316641019","article-title":"Clozapine-induced hypersalivation: an estimate of prevalence, severity and impact on quality of life","volume":"6","author":"Maher","year":"2016","journal-title":"Ther. Adv. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.schres.2022.02.035_bb0040","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00004714-199408000-00012","article-title":"Esophageal dysfunction in two patients after clozapine treatment","volume":"14","author":"McCarthy","year":"1994","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2022.02.035_bb0045","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000514615","article-title":"The prevalence and management of saliva problems in motor neuron disease: a 4-year analysis of the Scottish motor neuron disease register","volume":"20","author":"Pearson","year":"2020","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.schres.2022.02.035_bb0050","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2125.2006.02748.x","article-title":"Amitriptyline for clozapine-induced nocturnal enuresis and sialorrhoea","author":"Praharaj","year":"2007","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.schres.2022.02.035_bb0055","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/S0006-3223(96)89255-9","article-title":"The effect of clozapine on saliva flow rate: a pilot study","volume":"40","author":"Rabinowitz","year":"1996","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2022.02.035_bb0060","doi-asserted-by":"crossref","DOI":"10.2174\/1574886311666160426130252","article-title":"Very low dose amitriptyline for clozapine-associated sialorrhea","author":"Sinha","year":"2016","journal-title":"Curr. Drug Saf."},{"key":"10.1016\/j.schres.2022.02.035_bb0065","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/070674370705200607","article-title":"Clozapine-induced hypersalivation: a review of treatment strategies","volume":"52","author":"Sockalingam","year":"2007","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.schres.2022.02.035_bb0070","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/dmcn.14391","article-title":"Changes in severity and impact of drooling after submandibular gland botulinum neurotoxin a injections in children with neurodevelopmental disabilities","volume":"62","author":"Van Hulst","year":"2020","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.schres.2022.02.035_bb0075","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000118486","article-title":"Acute amitriptyline effects on parasympathetic-evoked rat saliva","volume":"20","author":"Yu","year":"1989","journal-title":"Neuropsychobiology"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099642200113X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099642200113X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:46:05Z","timestamp":1760298365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092099642200113X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":15,"alternative-id":["S092099642200113X"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2022.02.035","relation":{},"ISSN":["0920-9964"],"issn-type":[{"type":"print","value":"0920-9964"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amitriptyline for clozapine-induced hypersalivation: A case series","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2022.02.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}